Glaucoma Research Foundation
- Assets
- $14.4m
- Revenue
- $6.5m
- Investments
- $0.0
- Employees
- 11
- Location
- San Francisco, CA
- Founding
- 07/1978
- Data as of
- 06/2023
- EIN
- 94-2495035
Organization Overview
Glaucoma Research Foundation is located in San Francisco, CA. The organization was established in 1978. According to its NTEE Classification (H41) the organization is classified as: Eye Diseases, Blindness & Vision Impairments Research, under the broad grouping of Medical Research and related organizations. As of 06/2023, Glaucoma Research Foundation employed 11 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Glaucoma Research Foundation is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 06/2023, Glaucoma Research Foundation generated $6.5m in total revenue. This represents relatively stable growth, over the past 8 years the organization has increased revenue by an average of 5.9% each year. All expenses for the organization totaled $6.2m during the year ending 06/2023. While expenses have increased by 6.2% per year over the past 8 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Since 2016, Glaucoma Research Foundation has awarded 111 individual grants totaling $13,424,648. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
CURE GLAUCOMA AND RESTORE VISION THROUGH INNOVATIVE RESEARCH.
Describe the Organization's Program Activity:
Part 3 - Line 4a
THE ORGANIZATION PROMOTES AND SUPPORTS RESEARCH AND EDUCATION CONCERNING THE CAUSES AND TREATMENT OF GLAUCOMA. IT HAS BEEN A LEADER IN COLLABORATIVE RESEARCH THROUGH THE LANDMARK MULTI-CENTER NORMAL TENSION GLAUCOMA STUDY WHICH TRANSFORMED GLAUCOMA TREATMENT, AS WELL AS THE CREATION OF THE "CATALYST FOR A CURE" (CFC). THIS UNIQUE RESEARCH MODEL BRINGS TOGETHER SCIENTISTS FROM DIFFERENT DISCIPLINES TO WORK TOGETHER TO UNDERSTAND GLAUCOMA AND FIND WAYS TO IMPROVE TREATMENT AND FIND A CURE. THE FIRST CFC TEAM MADE A SIGNIFICANT IMPACT ON THE FIELD OF GLAUCOMA AND HELPED TO TRANSFORM THE UNDERSTANDING OF GLAUCOMA FROM AN EYE DISEASE TO A NEURODEGENERATIVE DISEASE.TAKING THE FINDINGS FROM THE FIRST TEAM, A SECOND CFC TEAM WAS CREATED TO DEVELOP NEW BIOMARKERS TO DIAGNOSE AND MANAGE GLAUCOMA MORE EFFECTIVELY BEFORE VISION IS LOST AND OPEN PATHWAYS TO NEW TREATMENT OPTIONS FOR PATIENTS. A THIRD CFC TEAM WAS LAUNCHED TO DISCOVER WAYS TO RESTORE VISION LOST TO GLAUCOMA BY RESTORING, REGENERATING OR REPLACING THE RETINAL GANGLION CELLS DAMAGED IN GLAUCOMA.A FOURTH CFC TEAM WAS LAUNCHED IN JULY TO INVESTIGATE COMMON MECHANISMS OF GLAUCOMA AND ALZHEIMER'S TO PREVENT AND CURE THESE AND OTHER NEURODEGENERATIVE DISEASES. THE ORGANIZATION ALSO PROVIDES FUNDING FOR INNOVATIVE PILOT STUDIES IN GLAUCOMA RESEARCH. THESE INCUBATOR GRANTS ENABLE SCIENTISTS TO INVESTIGATE A NOVEL AND PROMISING IDEA AND GATHER CRITICAL DATA TO CONTINUE THEIR RESEARCH AND SECURE ADDITIONAL FUNDING. THIS PROGRAM CONTINUES TO NURTURE THE CAREERS OF PROMISING GLAUCOMA INVESTIGATORS AND BRING NEW IDEAS TO THE FIELD OF GLAUCOMA RESEARCH. IN ADDITION, THE ORGANIZATION SERVES AS A PRIMARY SOURCE OF INFORMATION AND SUPPORT FOR PATIENTS BY PROVIDING UNBIASED EDUCATIONAL MATERIALS IN PRINT AND ONLINE.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Thomas M Brunner President & CEO | OfficerTrustee | 32 | $258,086 |
Nancy Graydon E.d. Devel. & COO | 40 | $244,991 | |
Andrew Jackson Dir. Communication | 40 | $141,649 | |
Catalina San Agustin Director Operation | 40 | $139,092 | |
Morgan Velarde Dir. Philanthropic | 40 | $104,261 | |
Michelle DE Elizalde Epstein Asst. Dir. Researc | 40 | $100,219 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
Jacqueline Jones Design Graphic Design, Printing | 6/29/23 | $371,697 |
Bryn Mawr Communications Advertising | 6/29/23 | $164,844 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $5,620,842 |
| Noncash contributions included in lines 1a–1f | $90,157 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $5,620,842 |
| Total Program Service Revenue | $391,050 |
| Investment income | $269,430 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $314 |
| Net Income from Fundraising Events | $184,795 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $6,480,467 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $2,393,328 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $50,000 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $271,226 |
| Compensation of current officers, directors, key employees. | $8,137 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $1,592,593 |
| Pension plan accruals and contributions | $0 |
| Other employee benefits | $0 |
| Payroll taxes | $0 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $0 |
| Fees for services: Accounting | $0 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $0 |
| Advertising and promotion | $0 |
| Office expenses | $0 |
| Information technology | $0 |
| Royalties | $0 |
| Occupancy | $213,749 |
| Travel | $0 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $0 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $0 |
| Insurance | $0 |
| All other expenses | $0 |
| Total functional expenses | $6,158,927 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $246,975 |
| Savings and temporary cash investments | $1,958,254 |
| Pledges and grants receivable | $3,547,953 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $27,390 |
| Prepaid expenses and deferred charges | $226,200 |
| Net Land, buildings, and equipment | $163,718 |
| Investments—publicly traded securities | $4,468,105 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $3,787,459 |
| Total assets | $14,426,054 |
| Accounts payable and accrued expenses | $224,948 |
| Grants payable | $925,000 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $381,165 |
| Total liabilities | $1,531,113 |
| Net assets without donor restrictions | $5,836,941 |
| Net assets with donor restrictions | $7,058,000 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $14,426,054 |
Grants Awarded
Over the last fiscal year, Glaucoma Research Foundation has awarded $2,385,500 in support to 15 organizations.
| Grant Recipient | Amount |
|---|---|
BAYLOR COLLEGE OF MEDICINE PURPOSE: GLAUCOMA RESEARCH | $50,000 |
BRIGHAM AND WOMENS HOSPITAL PURPOSE: GLAUCOMA RESEARCH | $185,500 |
GLAUCOMA REASERCH & EDUCATION PURPOSE: GLAUCOMA RESEARCH | $400,000 |
MASSACHUSETTS EYE & EAR PURPOSE: GLAUCOMA RESEARCH | $150,000 |
MAYO CLINIC PURPOSE: GLAUCOMA RESEARCH | $150,000 |
STANFORD UNIVERSITY PURPOSE: GLAUCOMA RESEARCH | $50,000 |